SCHEMBL4581440

SCHEMBL4581440

CCCCCCCCC(=O)NC(Cc1ccc(O)cc1)C(=O)O

nearest known ligand 0.67

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
FAAH O00519 2/20 0.67
ITGB3 P05106 3/20 0.66
ITGA2B P08514 3/20 0.66
GRIA1 P42261 1/20 0.62
CNR1 P21554 1/20 0.58
ALDH1A1 P00352 1/20 0.57
EPHX2 P34913 1/20 0.57
CHRND Q07001 5/20 0.56
NOD1 Q9Y239 1/20 0.56
CHRNA1 P02708 1/20 0.56
CHRNG P07510 1/20 0.56
CHRNB1 P11230 1/20 0.56
FOLH1 Q04609 1/20 0.54
NAALAD2 Q9Y3Q0 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6651208 1.00 FAAH (0.67) FAAHITGB3ITGA2BGRIA1CNR1
SCHEMBL6651206 1.00 FAAH (0.67) FAAHITGB3ITGA2BGRIA1CNR1
SCHEMBL16466484 1.00 FAAH (0.67) FAAHITGB3ITGA2BGRIA1CNR1
SCHEMBL4580946 1.00 FAAH (0.67) FAAHITGB3ITGA2BGRIA1CNR1
SCHEMBL4582828 1.00 FAAH (0.67) FAAHITGB3ITGA2BGRIA1CNR1
SCHEMBL28124 1.00 FAAH (0.67) FAAHITGB3ITGA2BGRIA1CNR1
SCHEMBL8371127 1.00 FAAH (0.67) FAAHITGB3ITGA2BGRIA1CNR1
SCHEMBL3452191 1.00 FAAH (0.67) FAAHITGB3ITGA2BGRIA1CNR1
SCHEMBL13279358 1.00 FAAH (0.67) FAAHITGB3ITGA2BGRIA1CNR1
SCHEMBL3802383 1.00 FAAH (0.67) FAAHITGB3ITGA2BGRIA1CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250000948-A1 SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID ADOCIA (FR) 2025-01-02 US disclosed
EP-4433093-A1 SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID Adocia (FR) 2024-09-25 EP disclosed
EP-4299057-A1 SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID Adocia (FR) 2024-01-03 EP disclosed
WO-2023084118-A1 SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID ADOCIA (FR) 2023-05-19 WO disclosed
EP-1888180-A2 SELF-TANNING COMPOSITION HAVING A UV PROTECTIVE EFFECT HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2008-02-20 EP disclosed
WO-2006131247-A2 SELF-TANNING COMPOSITION HAVING A UV PROTECTIVE EFFECT HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2006-12-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250000948-A1 SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID NPPA, BCAT1, ANPEP FAAH 858/4885ITGB3 4058/4885ITGA2B 3499/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.